|

Improving Minority Health Through Biofeedback and Stress Reduction

RECRUITINGN/ASponsored by Amelia Saul, PhD, CTRS, BCB
Actively Recruiting
PhaseN/A
SponsorAmelia Saul, PhD, CTRS, BCB
Started2025-09-15
Est. completion2026-03
Eligibility
Age18 Years – 35 Years
Healthy vol.Accepted
Locations1 site

Summary

This study aims to evaluate the effectiveness of a four-week heart rate variability (HRV) biofeedback intervention to improve physiological stress response, emotion regulation, and anxiety-related symptoms in young ethnic minority adults with a family history of cardiovascular disease (CVD). Participants will be randomly assigned to either an intervention group, where they will engage in guided paced breathing exercises, or a control group, which will follow standard conditions without the intervention. The study consists of five sessions, including an initial assessment, three weekly check-in sessions, and a final post-intervention assessment. Participants will practice paced breathing at home and attend brief in-lab sessions to track progress. Physiological and psychological measures, such as HRV, GSR, BP, anxiety levels, and responses to the Socially Evaluated Cold Pressor Test (SECPT), will be used to assess outcomes. Findings from this study may provide insights into accessible, non-invasive stress management interventions to mitigate CVD risk in high-risk populations.

Eligibility

Age: 18 Years – 35 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults
* Age 18 to 35 years
* Cognitively intact to follow instructions
* English-speaking
* Family history of cardiovascular disease.

Exclusion Criteria:

* Cognitive impairments that inhibit understanding instruction
* Current diagnosis of hypertension that is controlled with prescribed medication
* Previously receiving biofeedback training
* Having a severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes)
* Being actively psychotic
* Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data
* Patients currently taking medications such as MAOIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) are excluded due to their potential to affect the HRV data

Conditions7

AnxietyCardiovascular Disease Risk ReductionChronic StressEmotional RegulationHealth DisparitiesHeart DiseaseHypertension Prevention

Locations1 site

Florida International University
Miami, Florida, 33199
Amelia D Saul, PhD3053483472asaul@fiu.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.